Literature DB >> 12953146

Proteolysis of surfactant protein D by cystic fibrosis relevant proteases.

C von Bredow1, A Wiesener, M Griese.   

Abstract

Surfactant protein D (SP-D) is an important innate host defense molecule that has been shown to interact with cystic fibrosis (CF)-associated pathogens. Previous studies demonstrated that rat SP-D is highly resistant to degradation by a wide range of proteolytic enzymes. The aim of this study was to examine whether human SP-D can be degraded by CF relevant proteases ex vivo and in vitro. Bronchoalveolar lavage fluids (BALFs) of 11 patients with CF in a stable clinical condition were examined for SP-D by immunoblotting. In vitro, purified human SP-D was treated with human leukocyte elastase, proteinase 3, cathepsin G or Pseudomonas elastase followed by immunoblotting with specific antibodies to SP-D. In BALF of 8 of the 11 patients investigated, proteolytic fragments or absence of SP-D were detected. In vitro proteolysis of SP-D was observed in a time-dependent manner for each protease applied. The presence of Ca(++) at a physiologic concentration delayed, but did not prevent the degradation. We conclude that SP-D is an important target of numerous proteases present in the CF lung. Host defense is probably impaired due to proteolysis of SP-D and may contribute to the suppurative lung disease in CF.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12953146     DOI: 10.1007/s00408-003-1008-z

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  29 in total

1.  Surfactant protein D is a divalent cation-dependent carbohydrate-binding protein.

Authors:  A Persson; D Chang; E Crouch
Journal:  J Biol Chem       Date:  1990-04-05       Impact factor: 5.157

2.  A 50-kDa variant form of human surfactant protein D.

Authors:  R J Mason; L D Nielsen; Y Kuroki; E Matsuura; J H Freed; J M Shannon
Journal:  Eur Respir J       Date:  1998-11       Impact factor: 16.671

Review 3.  Interactions of surfactant protein D with pathogens, allergens and phagocytes.

Authors:  K B Reid
Journal:  Biochim Biophys Acta       Date:  1998-11-19

4.  Reduced proteolysis of surfactant protein A and changes of the bronchoalveolar lavage fluid proteome by inhaled alpha 1-protease inhibitor in cystic fibrosis.

Authors:  M Griese; C von Bredow; P Birrer
Journal:  Electrophoresis       Date:  2001-01       Impact factor: 3.535

5.  Interactions of surfactant protein D with bacterial lipopolysaccharides. Surfactant protein D is an Escherichia coli-binding protein in bronchoalveolar lavage.

Authors:  S F Kuan; K Rust; E Crouch
Journal:  J Clin Invest       Date:  1992-07       Impact factor: 14.808

6.  Degradation of surfactant protein D by alveolar macrophages.

Authors:  Q Dong; J R Wright
Journal:  Am J Physiol       Date:  1998-01

7.  Proteinase 3, a potent secretagogue in airways, is present in cystic fibrosis sputum.

Authors:  V Witko-Sarsat; L Halbwachs-Mecarelli; A Schuster; P Nusbaum; I Ueki; S Canteloup; G Lenoir; B Descamps-Latscha; J A Nadel
Journal:  Am J Respir Cell Mol Biol       Date:  1999-04       Impact factor: 6.914

8.  Aerosolized rhDNase in cystic fibrosis: effect on leucocyte proteases in sputum.

Authors:  T Rochat; F D Pastore; S E Schlegel-Haueter; I Filthuth; R Auckenthaler; D Belli; S Suter
Journal:  Eur Respir J       Date:  1996-11       Impact factor: 16.671

9.  Cleavage of lymphocyte surface antigens CD2, CD4, and CD8 by polymorphonuclear leukocyte elastase and cathepsin G in patients with cystic fibrosis.

Authors:  G Döring; F Frank; C Boudier; S Herbert; B Fleischer; G Bellon
Journal:  J Immunol       Date:  1995-05-01       Impact factor: 5.422

Review 10.  Structure, biologic properties, and expression of surfactant protein D (SP-D).

Authors:  E C Crouch
Journal:  Biochim Biophys Acta       Date:  1998-11-19
View more
  21 in total

1.  SerpinB1 in cystic fibrosis airway fluids: quantity, molecular form and mechanism of elastase inhibition.

Authors:  J Cooley; M K Sontag; F J Accurso; E Remold-O'Donnell
Journal:  Eur Respir J       Date:  2010-09-03       Impact factor: 16.671

2.  Surfactant protein D interacts with alpha2-macroglobulin and increases its innate immune potential.

Authors:  Hayley A Craig-Barnes; Barbara S Doumouras; Nades Palaniyar
Journal:  J Biol Chem       Date:  2010-03-05       Impact factor: 5.157

3.  Surfactant protein D is present in human tear fluid and the cornea and inhibits epithelial cell invasion by Pseudomonas aeruginosa.

Authors:  Minjian Ni; David J Evans; Samuel Hawgood; E Margot Anders; Robert A Sack; Suzanne M J Fleiszig
Journal:  Infect Immun       Date:  2005-04       Impact factor: 3.441

4.  Proteinase 3 is an IL-32 binding protein.

Authors:  Daniela Novick; Menachem Rubinstein; Tania Azam; Aharon Rabinkov; Charles A Dinarello; Soo-Hyun Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-17       Impact factor: 11.205

5.  Modification of surfactant protein D by reactive oxygen-nitrogen intermediates is accompanied by loss of aggregating activity, in vitro and in vivo.

Authors:  Sadis Matalon; Kedar Shrestha; Marion Kirk; Stephanie Waldheuser; Barbara McDonald; Kelly Smith; Zhiqian Gao; Abderrazzak Belaaouaj; Erika C Crouch
Journal:  FASEB J       Date:  2009-01-06       Impact factor: 5.191

6.  Intratracheal recombinant surfactant protein d prevents endotoxin shock in the newborn preterm lamb.

Authors:  Machiko Ikegami; Karen Carter; Kimberly Bishop; Annuradha Yadav; Elizabeth Masterjohn; William Brondyk; Ronald K Scheule; Jeffrey A Whitsett
Journal:  Am J Respir Crit Care Med       Date:  2006-03-23       Impact factor: 21.405

7.  Human neutrophil elastase degrades SPLUNC1 and impairs airway epithelial defense against bacteria.

Authors:  Di Jiang; Sally E Wenzel; Qun Wu; Russell P Bowler; Christina Schnell; Hong Wei Chu
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

8.  Comparative signature-tagged mutagenesis identifies Pseudomonas factors conferring resistance to the pulmonary collectin SP-A.

Authors:  Shiping Zhang; Yi Chen; Eric Potvin; Francois Sanschagrin; Roger C Levesque; Francis X McCormack; Gee W Lau
Journal:  PLoS Pathog       Date:  2005-11-25       Impact factor: 6.823

9.  NET balancing: a problem in inflammatory lung diseases.

Authors:  Olivia Z Cheng; Nades Palaniyar
Journal:  Front Immunol       Date:  2013-01-24       Impact factor: 7.561

10.  Truncated recombinant human SP-D attenuates emphysema and type II cell changes in SP-D deficient mice.

Authors:  Lars Knudsen; Matthias Ochs; Rosemarie Mackay; Paul Townsend; Roona Deb; Christian Mühlfeld; Joachim Richter; Fabian Gilbert; Samuel Hawgood; Kenneth Reid; Howard Clark
Journal:  Respir Res       Date:  2007-10-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.